Research topics SFI

Cost-effectiveness

The research theme “cost-effectiveness” investigates whether digital psychological treatments are cost-effective and examines factors that may influence cost-effectiveness. We focus on effects in terms of health-related quality of life and employment, how organizational factors can impact cost and effect, and we examine patients’ use of the digital treatments and their satisfaction with the solutions.

The work package/team is working with three different digital health services: the smartphone app Mamma Mia to prevent pregnancy depression, the sleep treatment program SHUTi aimed at insomnia, and eMeistring, a therapist-guided treatment for moderate depression, panic disorder, and social anxiety. Each of these three has several sub-studies associated with it:

  • Mamma Mia I: Cluster-randomized study of Mamma Mia where a self-help version is compared with self-help plus follow-up from health stations. Is special follow-up cost-effective in the short term? The study is conducted in close collaboration with the Regional Center for Child and Adolescent Mental Health, Eastern and Southern Norway (RBUP), and Changetech.

Contact person: Zareen Abbas Khan, PhD candidate, Silje Marie Haga, RBUP, and Filip Drozd, RBUP.

  • Mamma Mia II: A model-based analysis of Mamma Mia where a self-help version is compared both with self-help plus follow-up from health stations and without the digital offer at all. Is the Mamma Mia app cost-effective with a long-term perspective of 20 years? The study is conducted in close collaboration with the Regional Center for Child and Adolescent Mental Health, Eastern and Southern Norway (RBUP), Changetech, and the Department of Psychology at the University of Oslo.

Contact person: Zareen Abbas Khan, PhD candidate.

  • SHUTi: Randomized study where the self-help program SHUTi is compared with patient education via the internet. Is SHUTi a cost-effective measure over a two-year perspective? The study is conducted in close collaboration with St. Olavs Hospital.

Contact person: Zareen Abbas Khan, PhD candidate.

  • eMeistring Study I: We compare how eMeistring is organizationally implemented in four different health enterprises and the consequences for patient throughput and cost per patient. The study is conducted in close collaboration with Helse Bergen, Sykehuset i Vestfold, Sykehuset Innlandet, St. Olavs Hospital, and CheckWare.

Contact persons: Jørn Heggelund, postdoc, and Vidar Halsteinli, PhD/researcher.

  • eMeistring Study II: We investigate whether there are differences in cost and effect for patients treated at four health enterprises. The study is conducted in close collaboration with Helse Bergen, Sykehuset i Vestfold, Sykehuset Innlandet, St. Olavs Hospital, CheckWare, and Helse Vest IKT.

Contact persons: Zareen Abbas Khan, PhD candidate, Jørn Heggelund, postdoc, and Vidar Halsteinli, PhD/researcher.

  • eMeistring Study III: We investigate the relationship between patient characteristics/demographic variables, satisfaction with the system, and treatment effect. The study is conducted in close collaboration with Helse Bergen, Sykehuset i Vestfold, Sykehuset Innlandet, St. Olavs Hospital, CheckWare, and Helse Vest IKT. Contact person: Jørn Heggelund, postdoc.

Through these sub-studies, we aim to highlight the extent to which the costs of digital health services are reasonably aligned with various aspects of their effectiveness. The work is carried out in collaboration with work package 1 (effectiveness) and work package 4 (implementation). Several sub-studies are under planning.

The work package is led by Vidar Halsteinli, St. Olavs Hospital.

Vidar Halsteinli

E-postadresse

Health economist, researcher Regionalt Senter for helsetjenesteforskning (RSHU) St. Olavs hospital HF